Real-world use of nirmatrelvir-ritonavir: who benefits?

Lancet Infect Dis. 2023 Jul;23(7):765-767. doi: 10.1016/S1473-3099(23)00180-9. Epub 2023 Mar 15.

Authors

Kyle C Molina¹, Adit A Ginde²

Affiliations

¹ Department of Emergency Medicine, Colorado University School of Medicine, Aurora, CO, USA; Scripps Health, La Jolla, CA, USA. Electronic address: kyle.molina@cuanschutz.edu.
² Department of Emergency Medicine, Colorado University School of Medicine, Aurora, CO, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Humans
Ritonavir* / therapeutic use

Substances

nirmatrelvir
Ritonavir